Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
acetylcholinesterase, AChEI, algorithm, background, biomarker, carryover, CDC, clearance, Connecticut, CTDPA, daily, donepezil, hoc, immaterial, impression, interfering, mathematical, monotherapy, neurofilament, NfL, numerical, Online, overstatement, past, plasma, post, readout, rescheduled, reversal, reversed, staying, subgroup, Subscale, suggested, understatement, unused
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view